SCHEMBL23787794

SCHEMBL23787794

CCCc1cc(-c2ccc(/N=N/c3c(S(=O)(=O)O)cc4ccccc4c3O)c(CCC)c2)ccc1/N=N/c1c(S(=O)(=O)O)cc2ccccc2c1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PHLPP2 Q6ZVD8 2/20 0.52
▸ MPL P40238 3/20 0.49
▸ CTRC Q99895 1/20 0.49
▸ CYP1A2 P05177 4/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ DNASE1L3 Q13609 1/20 0.47
▸ CTRB1 P17538 1/20 0.46
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ HTT P42858 1/20 0.45
▸ ENPP2 Q13822 4/20 0.45
▸ ALDH1A1 P00352 2/20 0.43
▸ THRB P10828 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23787551 0.92 PHLPP2 (0.54) PHLPP2MPLCTRCCYP1A2CYP2C9
SCHEMBL23787730 0.88 ENPP2 (0.46) PHLPP2MPLCTRCCYP1A2CYP2C9
SCHEMBL23787696 0.85 PHLPP2 (0.57) PHLPP2CYP2C9MAPK1MEN1KMT2A
SCHEMBL23787674 0.83 PHLPP2 (0.49) PHLPP2MPLCTRCCYP1A2CYP2C9
SCHEMBL23787585 0.83 PHLPP2 (0.63) PHLPP2MPLCTRCCYP1A2CYP2C9
SCHEMBL23787644 0.83 CYP1A2 (0.47) PHLPP2MPLCTRCCYP1A2CYP2C9
SCHEMBL23787737 0.81 MPL (0.54) PHLPP2MPLCTRCCYP1A2CYP2C9
SCHEMBL23787586 0.81 MPL (0.54) PHLPP2MPLCTRCCYP1A2CYP2C9
SCHEMBL23787792 0.80 PHLPP2 (0.53) PHLPP2MPLCTRCCYP1A2CYP2C9
SCHEMBL23787548 0.80 ENPP2 (0.48) PHLPP2MPLCTRCCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF ACIBADEM MEHMET ALI AYDINLAR UNIVERSITESI (TR) 2021-09-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210275548-A1 NOVEL DNA POLYMERASE GAMMA INHIBITOR AND USES THEREOF POLG, POLB, POLA1 PHLPP2 1195/4885MPL 2115/4885CTRC 3691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback